Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Stock Advisor

Your next 5 stock picks, already researched. Just click.

Recently Viewed

Clear All

Gaudium IVF and Women Health IPO

Listed Listed stocks

IPO Rating

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Know more link icon

Gaudium IVF and Women Health IPO Details

  • Bidding Date

    20-Feb-2026 to
    24-Feb-2026

  • Issue Size

    ₹165 Cr

  • Price Band

    ₹75 to ₹79

  • Allotment date

    25-Feb-2026

  • Listing date

    27-Feb-2026

  • Lot size

    189

  • No. of shares

    2,08,86,200

  • Fresh issue/OFS

    ₹90 Cr/₹75 Cr

About Gaudium IVF and Women Health Company

Gaudium IVF and Women Health Limited, established in 2009 by Dr. Manika Khanna in Delhi, has expanded from a single fertility clinic into a network of over 30 state-of-the-art centers across six Indian states, evolving to encompass comprehensive women's health services including maternity care alongside its core infertility treatments. The primary focus remains advanced reproductive medicine, offering services such as IVF, IUI, ICSI, blastocyst culture, laser-assisted hatching, surrogacy, and solutions for failed IVF cycles, PCOS, endometriosis, male-factor infertility, and high-risk pregnancies, complemented by laparoscopic surgeries, hysteroscopy, and end-to-end maternity support. Key expertise lies in handling complex cases like recurrent IVF failures, supported by cutting-edge technologies including the INTEGRA Ti system, advanced egg quality evaluation, and WHO/GMP-compliant labs ensuring high success rates. Unique strengths include patient-centric, customized treatment plans, compassionate care, and a referral-center status for challenging infertility scenarios, serving domestic and international patients seeking reliable parenthood solutions. The company's operational philosophy emphasizes science-driven hope, personalized journeys, and ethical practices to address emotional, medical, and accessibility challenges in fertility and women's health.

Subscription Status

  • Category

    Status

  • QIBs

    1.6x

  • NIIs

    14.1x

  • Retail

    7.6x

  • Others

    --

  • Total

    7.3x

Gaudium IVF and Women Health Financials

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Horizon Reclaim (India) 98 - 103 12-Jun-2026 to 16-Jun-2026
Susan Electricals India 120 - 127 11-Jun-2026 to 15-Jun-2026
Leapfrog Engineering Services 21 - 23 17-Jun-2026 to 19-Jun-2026
Clay Craft India 193 - 203 17-Jun-2026 to 19-Jun-2026
IPO MonitorIPO Monitor

FAQs for Gaudium IVF and Women Health IPO.

The issue size of Gaudium IVF and Women Health is ₹165.00 Cr.

Gaudium IVF and Women Health falls into Healthcare & Services industry.

The Gaudium IVF and Women Health IPO will be listed on both NSE and BSE.

The open and close dates for the Gaudium IVF and Women Health are 20-Feb-2026 & 24-Feb-2026.

The price band for the Gaudium IVF and Women Health ipo is ₹75 to ₹79

The listing date of Gaudium IVF and Women Health IPO is 27-Feb-2026.

The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.

Gaudium IVF and Women Health total subscription ratio is 7.3X.

Key financial of the Gaudium IVF and Women Health are:


Gaudium IVF and Women Health FY-25 FY-24 FY-23
Revenue (₹ Cr) 70.72 47.89 44.24
EBIT (₹ Cr) 26.83 17.28 18.78
Proft after Tax (₹ Cr) 19.13 10.32 13.53
Debt (₹ Cr) 18.93 15.73 9.78
Net Worth (₹ Cr) 46.3 26.99 22.73
RoE (%) 41.31 38.23 59.51

Home > IPO Monitor > Gaudium IVF and Women Health